Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
0.4201
+0.0191 (4.76%)
Apr 1, 2025, 10:31 AM EDT - Market open
HSDT Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for HSDT.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for HSDT is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 16, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $5 → $24 | Strong Buy | Maintains | $5 → $24 | +5,612.93% | Mar 5, 2024 |
Maxim Group | Maxim Group | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +11,801.93% | Dec 20, 2022 |
Roth Capital | Roth Capital | Strong Buy Initiates $250 | Strong Buy | Initiates | $250 | +59,409.64% | Aug 23, 2022 |
Noble Capital Markets | Noble Capital Markets | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2021 |
Financial Forecast
Revenue This Year
520.20K
from 520.00K
Increased by 0.04%
Revenue Next Year
910.86K
from 520.20K
Increased by 75.10%
EPS This Year
-2.55
from -4.33
EPS Next Year
-2.33
from -2.55
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 535,500 | 937,650 |
Avg | 520,200 | 910,860 |
Low | 499,800 | 875,140 |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | 3.0% | 80.2% |
Avg | 0.0% | 75.1% |
Low | -3.9% | 68.2% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -2.63 | -2.39 |
Avg | -2.55 | -2.33 |
Low | -2.45 | -2.23 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.